Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.59 USD | -0.62% | +0.64% | -19.28% |
04-29 | Iterum Therapeutics Resubmits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem | CI |
03-28 | Transcript : Iterum Therapeutics plc, Q4 2023 Earnings Call, Mar 28, 2024 |
- Stock Market
- Equities
- ITRM Stock
- News Iterum Therapeutics plc
- MarketScreener Strategies